Vitality Watch

Dossier clinicaltrials trial early 11-sep-2026
Small or early-phase human trial or pilot study

Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults (EngAGE)

Key claim: EngAGE, an interactive voice-activated app, is being tested against usual care for improving physical and social function in multimorbid, frail, homebound older adults.

Abstract

The purpose of this study is to test the efficacy of EngAGE (an interactive, voice-activated app) vs usual care on improving older adult physical and social function.

Why this matters

Homebound multimorbid elders are the population most digital longevity tools quietly exclude; a voice-first modality that skips screens and touch UIs is a plausible delivery innovation for exactly that gap. The EngAGE trial is early-stage — the news here is that a voice-app is being subjected to a controlled efficacy test at all, not that benefit has been shown.

Source

Link

Briefing card

Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults (EngAGE)
Stage: trial early · clinicaltrials · 11-sep-2026

If you or a family member is homebound and multimorbid, this is an early trial of a voice-only app delivering mobility prompts — no results yet, so no efficacy claim to act on.

EngAGE, an interactive voice-activated app, is being tested against usual care for improving physical and social function in multimorbid, frail, homebound older adults.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT05337514

build build 880 · 2bcef25 · 2026-11-18